We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.05B
AUM Growth
+$394M
Cap. Flow
+$22.6M
Cap. Flow %
0.45%
Top 10 Hldgs %
24.03%
Holding
215
New
8
Increased
74
Reduced
105
Closed
7

Top Buys

Rank Stock Value
1
AES icon
AES
AES
+$43.4M
2
NVS icon
Novartis
NVS
+$14.1M
3
CPAY icon
Corpay
CPAY
+$12.8M
4
VMC icon
Vulcan Materials
VMC
+$11.5M
5
BR icon
Broadridge
BR
+$9.9M

Top Sells

Rank Stock Value
1
MAS icon
Masco
MAS
+$48.1M
2
NVDA icon
NVIDIA
NVDA
+$39.5M
3
BBWI icon
Bath & Body Works
BBWI
+$18.8M
4
APTV icon
Aptiv
APTV
+$12.9M
5
CSCO icon
Cisco
CSCO
+$10.8M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Technology 18.71%
3 Healthcare 15.59%
4 Industrials 10.32%
5 Consumer Discretionary 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBRG icon
201
DigitalBridge
DBRG
$2.95B
-3,575
Closed -$34K
EXPE icon
202
Expedia Group
EXPE
$37.3B
-6,155
Closed -$506K
HALO icon
203
Halozyme
HALO
$12.2B
-7,500
Closed -$201K
PPLI
204
People Inc
PPLI
$3.1B
-6,742
Closed -$390K
MTB icon
205
M&T Bank
MTB
$36.2B
-2,035
Closed -$212K
TRV icon
206
Travelers Companies
TRV
$80.2B
-1,992
Closed -$227K
XRAY icon
207
Dentsply Sirona
XRAY
$2.43B
-44,975
Closed -$1.98M
AHR
208
DELISTED
ANTHRACITE CAP INC
AHR
$0 ﹤0.01%
13,772

Similar funds

Douglas Lane & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Douglas Lane & Associates held 215 positions worth $5.05B, up 8.5% from $4.66B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Douglas Lane & Associates's Q3 2020 filing shows 8 new, 74 increased, 105 reduced and 7 closed positions. Its largest new stake was AES: 2,595,377 shares worth $47M. The largest sale was Masco, an estimated $48.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q3 2020 buy was AES: 2,595,377 shares worth $47M.
  • Douglas Lane & Associates added most to Novartis in Q3 2020, an estimated $14.1M increase.
  • Douglas Lane & Associates's biggest Q3 2020 reduction was Masco, cutting an estimated $48.1M.
  • Douglas Lane & Associates fully exited Dentsply Sirona in Q3 2020, selling an estimated $1.98M.
  • Douglas Lane & Associates's ten largest holdings make up 24% of its $5.05B portfolio in Q3 2020.
  • Douglas Lane & Associates opened 8 new positions and closed 7 in Q3 2020.
  • Douglas Lane & Associates's portfolio value rose 8.5% quarter-over-quarter to $5.05B.

Based on Douglas Lane & Associates's 13F filing for Q3 2020, filed 19 Oct 2020.